Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study

Abstract Background Denosumab (DMB) is a bone antiresorptive agent used to treat osteoporosis or metastatic cancer of the bones. However, denosumab-associated osteonecrosis of the jaw (DRONJ) has become a common complication in cancer patients. The prevalence of osteonecrosis of the jaw (ONJ) in can...

Full description

Bibliographic Details

Main Authors:	Ji-Yeon Kang, Sang-Yup Kim, Jae-Seok Lim, Jwa-Young Kim, Ga-Youn Jin, Yeon-Jung Lee, Eun-Young Lee
Format:	Artigo
Language:	Inglês
Published:	SpringerOpen 2023-06-01
Series:	Maxillofacial Plastic and Reconstructive Surgery
Subjects:	Denosumab Denosumab-related osteonecrosis of the jaws Necrosis of the jaws Cancer Anticancer drug
Online Access:	https://doi.org/10.1186/s40902-023-00391-9
Tags:	Add Tag No Tags, Be the first to tag this record!